First Trust Advisors LP lowered its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 98.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,376 shares of the company's stock after selling 2,085,539 shares during the quarter. First Trust Advisors LP's holdings in Avantor were worth $230,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. EverSource Wealth Advisors LLC grew its stake in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new position in shares of Avantor during the 2nd quarter valued at $32,000. Private Trust Co. NA boosted its position in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock worth $32,000 after purchasing an additional 875 shares in the last quarter. Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock worth $38,000 after acquiring an additional 1,064 shares in the last quarter. Finally, Los Angeles Capital Management LLC bought a new position in shares of Avantor in the 4th quarter worth $32,000. Institutional investors own 95.08% of the company's stock.
Wall Street Analysts Forecast Growth
AVTR has been the topic of several analyst reports. Morgan Stanley lifted their target price on Avantor from $10.00 to $14.00 and gave the company an "equal weight" rating in a research report on Thursday, July 30th. Zacks Research raised shares of Avantor from a "strong sell" rating to a "hold" rating in a report on Thursday, April 30th. Jefferies Financial Group upgraded shares of Avantor from an "underperform" rating to a "hold" rating and set a $13.00 target price for the company in a research report on Wednesday, July 29th. Citigroup boosted their price objective on Avantor from $9.00 to $11.00 and gave the company a "neutral" rating in a research note on Wednesday, July 8th. Finally, Sanford C. Bernstein assumed coverage on shares of Avantor in a research report on Friday, June 26th. They set a "market perform" rating and a $10.50 price target for the company. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Avantor presently has an average rating of "Hold" and a consensus price target of $12.00.
View Our Latest Stock Report on Avantor
Avantor Trading Down 0.4%
Shares of AVTR opened at $13.87 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The firm has a fifty day simple moving average of $11.12 and a two-hundred day simple moving average of $9.53. The stock has a market capitalization of $9.38 billion, a P/E ratio of -16.51, a PEG ratio of 10.49 and a beta of 0.89. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93.
Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.61 billion. During the same period in the previous year, the firm earned $0.24 earnings per share. The business's revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, research analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current year.
Avantor Company Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
See Also
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.